Stoke Therapeutics
STOK
#5029
Rank
NZ$2.87 B
Marketcap
NZ$50.38
Share price
-2.35%
Change (1 day)
144.41%
Change (1 year)

Earnings for Stoke Therapeutics (STOK)

Earnings in 2025 (TTM): NZ$75.81 Million

According to Stoke Therapeutics's latest financial reports the company's current earnings are NZ$0.20 Billion. In 2024 the company made an earning of -NZ$0.15 Billion, an increase over its 2023 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Stoke Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$75.81 M-151.32%
2024 -NZ$0.15 Billion-15.01%
2023 -NZ$0.18 Billion3.59%
2022 -NZ$0.17 Billion17.79%
2021 -NZ$0.15 Billion64.24%
2020 -NZ$86.75 Million61.62%
2019 -NZ$53.68 Million158.17%
2018 -NZ$20.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.25 Billion-464.89%๐Ÿ‡บ๐Ÿ‡ธ USA